Cipla
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Cipla House Peninsula Business Park Ganp...Phone Number
+91 2224826000Website
www.cipla.comRevenue
$3.1 BillionStock Symbol
500087Industry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
10
12
1
2
2
2
About Cipla
Cipla Limited is a global pharmaceutical company based in Mumbai, India, with operations in India, the United States, South Africa, and other international markets. Through its Pharmaceuticals and New Ventures segments, the company develops, manufactures, markets, and distributes a broad range of generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and finished formulations. Its products address multiple therapeutic areas, including cardiovascular disease, pulmonary and kidney conditions, neurological and psychiatric disorders, HIV/AIDS, respiratory and asthma care, oncology, diabetes and metabolic disorders, infectious diseases, critical care, women’s health, ophthalmology, and child health. In addition to its core pharmaceutical portfolio, Cipla is active in consumer healthcare, biosimilars, and specialty medicine businesses. Founded in 1935, Cipla has grown into a major global healthcare player.Explore more
Cipla Org Chart
HP
Inventory Assistant & Controller
BJ
Tender Debtors Controller
PP
Depot Finance Controller
SS
Stores Controller
LK
Warehouse Assistant & R2r Controller
MS
Financial Controller
JR
Financial Controller
KK
Procurement Controller
AA
Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cipla your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Cipla is spiking on competitors!
Cipla, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cipla has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cipla
Funding: Get notified immidiatlly once Cipla has new funding data
Click to see if Cipla had a recent Job posting/layoffs
Earning: See what the market has to say on Cipla recently announced quarterly report
Product Launch: Get notified when Cipla launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Cipla as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cipla is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cipla is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cipla.
Cipla Tech Stack
A closer look at the technologies used by Cipla
Most Recent Scoops
Person-Based
Acquisitions, Corporate Strategy
New Hire
Executive Move
Executive Moves, New Hire
Hiring Plans
Cipla has more open roles in Sales than it has had at any time in the past 12 months. Areas of expertise include: Profit-Based Sales Targets, Sales Planning, and Selling Techniques.
Hiring Plans
Person-Based
Earnings, Finance
Person-Based
Product Launch, Manufacturing Operations
Cipla News & Media
Pentoxifylline Drug Market Is Going to Boom Rapidly | Sanofi India Ltd, ANI Pharmaceuticals Inc, Cipla Ltd
The Global Pentoxifylline Drug Market is estimated to be valued at USD 515.2 Mn in 2026 and is expected to reach USD 821.8 Mn by 2033. BURLINGAME, CA, UNITED STATES, May 7, 2026 /EINPresswire.com/ -- The Global Pentoxifylline Drug Market is estimated to …Pfizer Reaches Three Settlement Agreements for VYNDAMAX
Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in the U.S. District Court for the District of Delaware for infringement of patents relating to VYNDAMAX ® (tafamidis), a treatment for cardiomyopathy transthyretin-mediated amyloidosis (ATTR-CM). These settlements extend the effective U.S. patent expiry date for VYNDAMAX to June 1, 2031, subject to thePfizer Reaches Three Settlement Agreements for VYNDAMAX - Yahoo Finance
NEW YORK, April 28, 2026--Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in the U.S. District Court for the District of Delaware for infringement of patents relating to VYNDAMAX® (tafamidis), a treatment for cardiomyopathy transthyretin-mediated amyloidosis (ATTR-CM). These settlements extend the effective U.S. patent expiry date for VYNDAMAX to JunCipla receives FDA nod for first generic Ventolin HFA
Albuterol sulfate inhalation aerosol is used to treat or prevent bronchospasm with reversible obstructive airway disease.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Cipla
Sign Up For FreeTo access detailed company insights
Cipla Limited is a global pharmaceutical company based in Mumbai, India, with operations in India, the United States, South Africa, and other international markets. Through its Pharmaceuticals and New Ventures segments, the company develops, manufactures, markets, and distributes a broad range of generic and branded generic medicines, vaccines, act... Read More
